A phase II dose-ranging study of mirabegron in patients with overactive bladder (Q37100337)

From Wikidata
Jump to navigation Jump to search
scientific article published on 08 March 2013
edit
Language Label Description Also known as
English
A phase II dose-ranging study of mirabegron in patients with overactive bladder
scientific article published on 08 March 2013

    Statements

    A phase II dose-ranging study of mirabegron in patients with overactive bladder (English)
    0 references
    Vladimir Dvorak
    Pjotr Radziszewski
    Philip Van Kerrebroeck
    Brigitte Bosman
    Peter Boerrigter
    Ted Drogendijk
    Arwin Ridder
    Ingrid Van Der Putten-Slob
    Osamu Yamaguchi
    Dragon Investigator Group
    8 March 2013
    1447-1458

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit